window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-108383172-1');

Interview Jan Groen: Colorectal Cancer Blood Test Driven by Immuno-transcriptomics

By |2024-06-17T20:29:41+02:0019 June 2019|News Novigenix|

Source: TN Michele Wilson PhD Science Writer Immuno-transcriptomics is a field of study focused on analyzing gene expression modifications (mRNA signatures) induced by the immune response to various triggers, such as the onset of cancer. Through deep neural network and machine learning, Novigenix are generating mathematical models based on these mRNA signature analyses to

Novigenix Appoints Dr. Jan Groen as CEO to Lead Expansion to Multi-Product Cancer Diagnostic Platform Company

By |2024-06-17T20:48:34+02:0013 May 2019|Communiqué de presse, News Novigenix|

ImmunoTranscriptomic platform combines identification of immune cell mRNA signatures with AI for early cancer detection LAUSANNE, SWITZERLAND - 07:00 CET, May 13, 2019 - Novigenix SA, a leading ImmunoTranscriptomics company that develops and commercializes products for early cancer detection and precision medicine today announced the appointment of Dr. Jan Groen to the position of Chief

Novigenix nomme Jan Groen au poste de CEO pour conduire la transition de la société vers une plateforme technologique de diagnostic du cancer et de médecine de précision

By |2024-06-17T20:48:23+02:0013 May 2019|Communiqué de presse, News Novigenix|

La plateforme ImmunoTranscriptomic combine l'identification des signatures d'ARNm de cellules immunitaires avec l'IA pour la détection précoce du cancer LAUSANNE, SUISSE - 7h00, CET, 13 mai 2019 - Novigenix SA, une société pionnière en ImmunoTranscriptomics qui développe et commercialise des produits pour la détection précoce du cancer et la médecine de précision a annoncé

Go to Top